Baseline and clinical characteristics of the study sample, stratified by the occurrence of MACEsa
Subjects | Total (n = 176) | Non-MACE Group (n = 142) | MACE Group (n = 34) | P Value |
---|---|---|---|---|
Age (yr) | 69.3 (SD, 7.6) | 69.3 (SD, 7.7) | 69.2 (SD, 6.8) | .49 |
Median (IQR) (yr) | 70 (64–75) | 69 (64–75) | 71 (66–75) | |
Male sex | 156 (88.6) | 126 (88.7) | 30 (88.2) | .998 |
Body mass index (kg/m2) | 24.5 (SD, 3.1) | 24.5 (SD, 3.0) | 24.4 (SD, 3.4) | .96 |
Risk factors | ||||
Diabetes mellitus | 76 (43.2) | 66 (46.5) | 10 (29.4) | .096 |
Hypertension | 126 (71.6) | 101 (71.1) | 25 (73.5) | .80 |
Dyslipidemia | 96 (54.6) | 77 (54.2) | 19 (55.9) | .60 |
Current smoking | 43 (24.4) | 32 (22.5) | 11 (32.4) | .42 |
Past smoking | 68 (38.6) | 56 (39.4) | 12 (35.3) | .91 |
Atrial fibrillation | 9 (5.1) | 5 (3.5) | 4 (11.8) | .001 |
Medical history | ||||
History of strokeb | 56 (31.8) | 44 (31.0) | 12 (35.3) | .66 |
History of ACSb | 30 (17.1) | 21 (14.8) | 9 (26.5) | .30 |
Antiplatelet | 154 (87.5) | 124 (87.3) | 30 (88.2) | .72 |
Statins | 142 (80.7) | 115 (81.0) | 27 (79.4) | .47 |